PERTUSSIS IN BRAZILIAN CHILDREN- MORTALITY, LENGTH OF STAY, AND COSTS IN HOSPITALIZED PATIENTS
Author(s)
Haas LC;Fernandes RA*;Takemoto M;Silva MA;Vasconcellos JF;Amaral LM, Menezes LP ANOVA, Rio de Janeiro, Brazil
Presentation Documents
OBJECTIVES: Bordetella pertussis infection is highly contagious and can progress to severe conditions, especially among young children and elderly. This study aims to describe hospitalization patterns and costs for pertussis in children in public hospitals in Brazil, from 2008 to 2011. METHODS: A retrospective analysis of Brazil public hospital admissions for pertussis was developed according to ICD-10 classification (A37: Pertussis) in children (aged ≤9 years), as reported in Brazilian Hospital Information System (SIH/DATASUS) database from January 2008 to December 2011. Costs represents federal reimbursement values for hospitalizations (includes medical procedures, exams, medications and taxes), presented in 2013 Brazilian Real (BRL). RESULTS: A total of 3,055 hospital admissions for pertussis during the four-year period were identified. There was a downward trend in the first three years of the analysis, while the opposite occurred in the fourth year, with 2011 having the highest number of cases (907, 655, 394 and 1,099 for 2008, 2009, 2010, and 2011, respectively). Infants were the most affected, with those less than one year of age accounting for 91% (n = 2,779) of all pertussis admissions in the age group analyzed. In-hospital mortality rate was 13.9% for all cause in the period. Mean length of stay was 7.56 days. Total cost for the period was 3,754,877 BRL, which represents 94.9% of pertussis hospitalization costs for all ages (3,958,133 BRL). Mean cost per patient was 1,229 BRL. CONCLUSIONS: The costs with pertussis hospitalizations in children can be substantial in Brazil, from the public healthcare perspective. Despite the existence of a National Immunization Program, the number of cases in children remains high. It is therefore important that decision makers reassess the prevention and treatment patterns of this disease.
Conference/Value in Health Info
2013-11, ISPOR Europe 2013, The Convention Centre Dublin
Value in Health, Vol. 16, No. 7 (November 2013)
Code
PIN42
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Infectious Disease (non-vaccine)